These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7910120

  • 21. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA, Stiles GL, Shand DG.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Propafenone interacts stereoselectively with beta 1- and beta 2-adrenergic receptors.
    Burnett DM, Gal J, Zahniser NR, Nies AS.
    J Cardiovasc Pharmacol; 1988 Feb; 12(5):615-9. PubMed ID: 2468063
    [Abstract] [Full Text] [Related]

  • 24. The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
    Cai WM, Chen B, Cai MH, Chen Y, Zhang YD.
    Br J Clin Pharmacol; 1999 May; 47(5):553-6. PubMed ID: 10336580
    [Abstract] [Full Text] [Related]

  • 25. Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers.
    Chen X, Zhong D, Blume H.
    Eur J Pharm Sci; 2000 Mar; 10(1):11-6. PubMed ID: 10699379
    [Abstract] [Full Text] [Related]

  • 26. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
    Valenzuela C, Snyders DJ, Bennett PB, Tamargo J, Hondeghem LM.
    Circulation; 1995 Nov 15; 92(10):3014-24. PubMed ID: 7586272
    [Abstract] [Full Text] [Related]

  • 27. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK, Kirstein M.
    J Electrocardiol; 2002 Oct 15; 35(4):343-9. PubMed ID: 12395362
    [Abstract] [Full Text] [Related]

  • 28. Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance.
    Malfatto G, Pessano P, Zaza A, Schwartz PJ.
    Eur Heart J; 1993 Sep 15; 14(9):1253-7. PubMed ID: 7901020
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG, Kirsten EB, Brewington J.
    Clin Pharmacol Ther; 1989 May 15; 45(5):535-41. PubMed ID: 2721109
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine.
    Pritchett EL, Smith WM, Kirsten EB.
    J Clin Pharmacol; 1988 Jul 15; 28(7):619-24. PubMed ID: 3063727
    [Abstract] [Full Text] [Related]

  • 32. Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein.
    Oravcová J, Lindner W, Szalay P, Bohácik L, Trnovec T.
    Chirality; 1991 Jul 15; 3(1):30-4. PubMed ID: 2039682
    [Abstract] [Full Text] [Related]

  • 33. Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers.
    Zhou Q, Yao TW, Zeng S.
    World J Gastroenterol; 2001 Dec 15; 7(6):830-5. PubMed ID: 11854911
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol.
    Dhand R, Goode M, Reid R, Fink JB, Fahey PJ, Tobin MJ.
    Am J Respir Crit Care Med; 1999 Oct 15; 160(4):1136-41. PubMed ID: 10508799
    [Abstract] [Full Text] [Related]

  • 37. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.
    Isoherranen N, Yagen B, Woodhead JH, Spiegelstein O, Blotnik S, Wilcox KS, Finnell RH, Bennett GD, White HS, Bialer M.
    Br J Pharmacol; 2003 Feb 15; 138(4):602-13. PubMed ID: 12598414
    [Abstract] [Full Text] [Related]

  • 38. [The bioequivalence of two oral propafenone preparations].
    Koytchev R, Alken RG, Mayer O, Böhm R, Ellrich A, Waldner-Kölblin RG.
    Arzneimittelforschung; 1995 May 15; 45(5):542-5. PubMed ID: 7612052
    [Abstract] [Full Text] [Related]

  • 39. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
    Kern R.
    Methods Find Exp Clin Pharmacol; 1994 Apr 15; 16(3):203-10. PubMed ID: 7913980
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.